Metered dose inhaler: Past, present, and future

Surender K. Vaswani; Peter S. Creticos

doi:10.1016/s1081-1206(10)62933-x

Metered dose inhaler: Past, present, and future

Surender K. Vaswani, Peter S. Creticos

Research output: Contribution to journal › Review article › peer-review

18 Scopus citations

Abstract

Background: The metered dose inhaler (MDI) to treat respiratory diseases was introduced many years ago. Due to the recently proposed ban on chlorofluorocarbon (Freon) production, the survival of the conventional MDI is uncertain. It is therefore incumbent on asthma caretakers to familiarize themselves with newer versions of the inhaler. Objective: To review the different modalities of aerosolized treatment employed in the management of asthma. This article is specifically focused on issues related to MDIs, the propellants, and the modifications since its introduction. Data Source: The MEDLINE database was used to review MDI related literature in the English language. Conclusion: Dry powder inhalers (especially the multi-dose type) and Freon-free pressurized MDIs appear promising and probably will replace conventional freonpropelled pressurized MDIs when Freon is no longer available.

Original language	English (US)
Pages (from-to)	11-20
Number of pages	10
Journal	Annals of Allergy, Asthma and Immunology
Volume	80
Issue number	1
DOIs	https://doi.org/10.1016/s1081-1206(10)62933-x
State	Published - Jan 1998
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Pulmonary and Respiratory Medicine

Access to Document

10.1016/s1081-1206(10)62933-x

Cite this

@article{4b51045997e643ffb9773a3432e3bd4a,

title = "Metered dose inhaler: Past, present, and future",

abstract = "Background: The metered dose inhaler (MDI) to treat respiratory diseases was introduced many years ago. Due to the recently proposed ban on chlorofluorocarbon (Freon) production, the survival of the conventional MDI is uncertain. It is therefore incumbent on asthma caretakers to familiarize themselves with newer versions of the inhaler. Objective: To review the different modalities of aerosolized treatment employed in the management of asthma. This article is specifically focused on issues related to MDIs, the propellants, and the modifications since its introduction. Data Source: The MEDLINE database was used to review MDI related literature in the English language. Conclusion: Dry powder inhalers (especially the multi-dose type) and Freon-free pressurized MDIs appear promising and probably will replace conventional freonpropelled pressurized MDIs when Freon is no longer available.",

author = "Vaswani, {Surender K.} and Creticos, {Peter S.}",

year = "1998",

month = jan,

doi = "10.1016/s1081-1206(10)62933-x",

language = "English (US)",

volume = "80",

pages = "11--20",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "American College of Allergy, Asthma and Immunology",

number = "1",

}

TY - JOUR

T1 - Metered dose inhaler

T2 - Past, present, and future

AU - Vaswani, Surender K.

AU - Creticos, Peter S.

PY - 1998/1

Y1 - 1998/1

N2 - Background: The metered dose inhaler (MDI) to treat respiratory diseases was introduced many years ago. Due to the recently proposed ban on chlorofluorocarbon (Freon) production, the survival of the conventional MDI is uncertain. It is therefore incumbent on asthma caretakers to familiarize themselves with newer versions of the inhaler. Objective: To review the different modalities of aerosolized treatment employed in the management of asthma. This article is specifically focused on issues related to MDIs, the propellants, and the modifications since its introduction. Data Source: The MEDLINE database was used to review MDI related literature in the English language. Conclusion: Dry powder inhalers (especially the multi-dose type) and Freon-free pressurized MDIs appear promising and probably will replace conventional freonpropelled pressurized MDIs when Freon is no longer available.

AB - Background: The metered dose inhaler (MDI) to treat respiratory diseases was introduced many years ago. Due to the recently proposed ban on chlorofluorocarbon (Freon) production, the survival of the conventional MDI is uncertain. It is therefore incumbent on asthma caretakers to familiarize themselves with newer versions of the inhaler. Objective: To review the different modalities of aerosolized treatment employed in the management of asthma. This article is specifically focused on issues related to MDIs, the propellants, and the modifications since its introduction. Data Source: The MEDLINE database was used to review MDI related literature in the English language. Conclusion: Dry powder inhalers (especially the multi-dose type) and Freon-free pressurized MDIs appear promising and probably will replace conventional freonpropelled pressurized MDIs when Freon is no longer available.

UR - http://www.scopus.com/inward/record.url?scp=0031933515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031933515&partnerID=8YFLogxK

U2 - 10.1016/s1081-1206(10)62933-x

DO - 10.1016/s1081-1206(10)62933-x

M3 - Review article

C2 - 9475561

AN - SCOPUS:0031933515

SN - 1081-1206

VL - 80

SP - 11

EP - 20

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

IS - 1

ER -

Metered dose inhaler: Past, present, and future

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this